Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pulmonary arterial hypertension: new ideas and perspectives.

Literature DB >> 11250981

Pulmonary arterial hypertension: new ideas and perspectives.

N Galiè¹, A Torbicki.

Abstract

Entities: Disease

Mesh：

Year: 2001 PMID： 11250981 PMCID： PMC1729670 DOI： 10.1136/heart.85.4.475

Source DB: PubMed Journal: Heart ISSN： 1355-6037 Impact factor: 5.994

× No keyword cloud information.

27 in total

1. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.

Authors: L J Rubin; J Mendoza; M Hood; M McGoon; R Barst; W B Williams; J H Diehl; J Crow; W Long
Journal: Ann Intern Med Date: 1990-04-01 Impact factor: 25.391

2. Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hypertension. Immediate and long-term results in 42 patients.

Authors: K M Moser; P O Daily; K Peterson; W Dembitsky; J M Vapnek; D Shure; J Utley; C Archibald
Journal: Ann Intern Med Date: 1987-10 Impact factor: 25.391

3. More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited.

Authors: R Naeije; A Torbicki
Journal: Eur Respir J Date: 1995-09 Impact factor: 16.671

4. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension.

Authors: J A Feinstein; S Z Goldhaber; J E Lock; S M Ferndandes; M J Landzberg
Journal: Circulation Date: 2001-01-02 Impact factor: 29.690

5. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

Authors: R D Machado; M W Pauciulo; J R Thomson; K B Lane; N V Morgan; L Wheeler; J A Phillips; J Newman; D Williams; N Galiè; A Manes; K McNeil; M Yacoub; G Mikhail; P Rogers; P Corris; M Humbert; D Donnai; G Martensson; L Tranebjaerg; J E Loyd; R C Trembath; W C Nichols
Journal: Am J Hum Genet Date: 2000-12-12 Impact factor: 11.025

6. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.

Authors: G G Pietra; W D Edwards; J M Kay; S Rich; J Kernis; B Schloo; S M Ayres; E H Bergofsky; B H Brundage; K M Detre
Journal: Circulation Date: 1989-11 Impact factor: 29.690

7. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension.

Authors: K M Moser; C M Bloor
Journal: Chest Date: 1993-03 Impact factor: 9.410

8. Do patients with primary pulmonary hypertension develop extensive central thrombi?

Authors: K M Moser; P F Fedullo; W E Finkbeiner; J Golden
Journal: Circulation Date: 1995-02-01 Impact factor: 29.690

9. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.

Authors: R J Barst; L J Rubin; W A Long; M D McGoon; S Rich; D B Badesch; B M Groves; V F Tapson; R C Bourge; B H Brundage; S K Koerner; D Langleben; C A Keller; S Murali; B F Uretsky; L M Clayton; M M Jöbsis; S D Blackburn; D Shortino; J W Crow
Journal: N Engl J Med Date: 1996-02-01 Impact factor: 91.245

Pulmonary arterial hypertension: new ideas and perspectives.

1. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.

2. Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hypertension. Immediate and long-term results in 42 patients.

3. More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited.

4. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension.

5. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

6. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.

7. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension.

8. Do patients with primary pulmonary hypertension develop extensive central thrombi?

9. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.

10. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

1. Dissolution of tungsten coils leads to device failure after transcatheter embolisation of pathologic vessels.

2. Progressive ECG changes before the onset of atrial flutter in adult congenital heart disease patients.

3. Altered CD18 leucocyte integrin expression and adhesive function in patients with an acute coronary syndrome.

4. Increased pulmonary arterial pressure in children with nephrotic syndrome.